Our findings raise the possibility that IMP3 expression may be effectively used to distinguish teratomas of benign versus malignant potential, even when FISH studies are not available or are unsuccessful; however, a validation study on a large, multi-institutional cohort is necessary for verification. Here, IMP3 is linked to teratoma.